跳至主要内容
临床试验/NCT01401907
NCT01401907已完成不适用

Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Advanced Lung and Non-colorectal Gastrointestinal Malignancies

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 351 人开始时间: 2011年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
351
试验地点
1
主要终点
Functional Assessment of Cancer Therapy (Quality of Life Measure)

研究概览

简要总结

The purpose of this study is to compare two types of care - standard oncology care and standard oncology care with early palliative care (started soon after diagnosis) to see which is better for improving the experience of patients and families with advanced lung and non-colorectal GI cancer. The study will use questionnaires to measure patients' and caregivers' quality of life, mood, coping and understanding of their illness.

详细描述

Subjects and their caregiver will complete a baseline questionnaire and then be randomized to a study group.

Subjects who are randomized to Standard Oncology Care will follow up with their treating oncologist. They will consult with the palliative care team at their request or at the request of the treating oncologist. They will complete questionnaires at 12 weeks and 24 weeks after enrollment.

Subjects who are randomized to the Standard Oncology Care with Early Palliative Care will meet with a palliative care clinician at their next medical oncology visit or infusion visit. They will meet with the palliative care clinician at least every three weeks. They will complete questionnaires at 12 and 24 weeks after enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Confirmed metastatic lung cancer (NSCLC, small cell lung cancer, and mesothelioma)or non-colorectal GI cancer (esophageal, gastric and hepatobiliary) not being treated with curative intent
  • •Informed of metastatic disease within the previous 8 weeks
  • •No prior therapy for metastatic disease
  • •Able to read questions in English or willing to complete questionnaires with the assistance of an interpreter
  • •Relative or friend of patient who will likely accompany the patient to clinic visits

排除标准

  • •Significant psychiatric or other co-morbid disease

研究组 & 干预措施

Early Palliative Care

Experimental

Subjects receive standard of care with early palliative care.

干预措施: early palliative care (Other)

Standard of Care

No Intervention

Subjects receives standard of care

结局指标

主要结局

Functional Assessment of Cancer Therapy (Quality of Life Measure)

时间窗: 12 weeks

The Functional Assessment of Cancer Therapy - General is a quality of life measure with higher scores indicating better quality of life (range 0-108). We are examining the adjusted mean difference from baseline to 12 weeks in this study

次要结局

  • Rate of Clinically Significant Depression Symptoms Based on Hospital Anxiety and Depression Scale(Week-12 and Week-24)
  • Coping (Brief Cope)(Up to week-24)
  • Functional Assessment of Cancer Therapy (Quality of Life Measure)(24 weeks)
  • Family Caregiver Psychological Distress (Based on the Hospital Anxiety and Depression Scale)(Week 12 and Week 24)
  • Number and Percentage of Participants Who Reported Goal of Their Cancer Treatment is to Cure Their Cancer(Week12 and Week 24)
  • Number and Percentage of Family Caregivers Who Reported the Goal of Treatment is to Cure Cancer(12 and 24 weeks)
  • Family Caregiver Quality of Life as Measured by the SF-36(Week-12 and Week-24)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Temel, MD

Principal Investigator

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验